Ronald Hunt
SlowingNamed in filings at New LeafOn the current fund
- Board seats filed
- 11
- Named on a board
- 1
all filings on record
Named in filings at New LeafOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Westminster Financial Companies | Fintech | — | None on file |
| Abcuro | Biotech & pharma | August 2026 | Partners Innovation |
| Rallybio Holdings | Biotech & pharma | March 2020 | None on file |
| Iterum Therapeutics Bermuda | Biotech & pharma | January 2020 | Capra CLO Founders, Sofinnova Venture Partners |
| Qlaris Bio | Biotech & pharma | August 2019 | None on file |
| CuraSen Therapeutics | Biotech & pharma | September 2018 | Longitude Capital |
| Harpoon Therapeutics | Biotech & pharma | May 2017 | MPM BioVentures |
| Iterum Therapeutics plc | Biotech & pharma | November 2015 | None on file |
| Neuronetics | Medical devices | November 2014 | Atlas Venture |
| IlluminOss Medical | Medical devices | June 2014 | Amzl, Synapse Investment |
| AMERICAN CHARTERED BANCORP | Not yet classified | December 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Ronald Hunt on the board, based on 10 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.